• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

记忆性T细胞无法诱发移植物抗宿主病是无效同种异体反应的结果。

Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.

作者信息

Chen Benny J, Deoliveira Divino, Cui Xiuyu, Le Ngocdiep T, Son Jessica, Whitesides John F, Chao Nelson J

机构信息

Division of Cellular Therapy/Bone Marrow Transplantation, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Blood. 2007 Apr 1;109(7):3115-23. doi: 10.1182/blood-2006-04-016410.

DOI:10.1182/blood-2006-04-016410
PMID:17148592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1852216/
Abstract

Several groups, including our own, have independently demonstrated that effector memory T cells from non-alloantigen-primed donors do not cause graft-versus-host disease (GVHD). In the current study, we further investigated whether this approach could be extended to all memory T cells, and we studied the underlying mechanisms. Neither total memory T cells nor purified central memory T cells were able to induce GVHD. Memory T cells were at least 3-log less potent than bulk T cells in mediating GVHD. As expected, memory T cells failed to elicit cytotoxicity and proliferated poorly against alloantigens in standard 5-day mixed-lymphocyte cultures. However, the proliferative responses of memory T cells were more comparable with those of bulk and naive T cells when the culture time was shortened. Moreover, the frequencies of IL-2-secreting cells measured by 42-hour enzyme-linked immunosorbent spot (ELISPOT) assay were similar among naive, memory, and bulk T cells. These data indicated that memory T cells are able to respond to alloantigens initially but fail to develop to full potential. The abortive immune response, which was mediated by non-alloantigen-specific memory T cells in response to alloantigens, may explain why memory T cells from unprimed and non-alloantigen-primed donors could not induce GVHD.

摘要

包括我们自己的研究小组在内的几个团队已经独立证明,来自未接受过同种异体抗原刺激的供体的效应记忆T细胞不会引发移植物抗宿主病(GVHD)。在当前的研究中,我们进一步研究了这种方法是否可以扩展到所有记忆T细胞,并研究了其潜在机制。无论是总记忆T细胞还是纯化的中枢记忆T细胞都无法诱导GVHD。在介导GVHD方面,记忆T细胞的效力比大量T细胞至少低3个对数。正如预期的那样,在标准的5天混合淋巴细胞培养中,记忆T细胞未能引发细胞毒性,并且对同种异体抗原的增殖能力较差。然而,当缩短培养时间时,记忆T细胞的增殖反应与大量T细胞和幼稚T细胞的增殖反应更具可比性。此外,通过42小时酶联免疫吸附斑点(ELISPOT)测定法测量的白细胞介素-2分泌细胞的频率在幼稚T细胞、记忆T细胞和大量T细胞中相似。这些数据表明,记忆T细胞能够最初对同种异体抗原作出反应,但无法充分发挥其潜力。由非同种异体抗原特异性记忆T细胞对同种异体抗原介导的流产免疫反应,可能解释了为什么来自未致敏和未接受过同种异体抗原刺激的供体的记忆T细胞不能诱导GVHD。

相似文献

1
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.记忆性T细胞无法诱发移植物抗宿主病是无效同种异体反应的结果。
Blood. 2007 Apr 1;109(7):3115-23. doi: 10.1182/blood-2006-04-016410.
2
Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.同种异体特异性 CD4(+)效应记忆 T 细胞不会在小鼠中引起移植物抗宿主病。
Biol Blood Marrow Transplant. 2012 Oct;18(10):1488-99. doi: 10.1016/j.bbmt.2012.07.009. Epub 2012 Jul 15.
3
Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.同种异体反应性记忆T细胞是移植物抗宿主病持续存在的原因。
J Immunol. 2005 Mar 1;174(5):3051-8. doi: 10.4049/jimmunol.174.5.3051.
4
Naive and memory T cells induce different types of graft-versus-host disease.初始T细胞和记忆T细胞会引发不同类型的移植物抗宿主病。
J Immunol. 2007 Nov 15;179(10):6547-54. doi: 10.4049/jimmunol.179.10.6547.
5
Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation.对体外同种异体抗原刺激无反应的T细胞诱导急性移植物抗宿主病。
Br J Haematol. 2004 Sep;126(6):828-36. doi: 10.1111/j.1365-2141.2004.05131.x.
6
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.异体CD62L记忆性T细胞的转移且无移植物抗宿主病。
Blood. 2004 Feb 15;103(4):1534-41. doi: 10.1182/blood-2003-08-2987. Epub 2003 Oct 9.
7
Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.供体T细胞亚群延迟输注后的移植物抗宿主反应和移植物抗白血病反应。
Biol Blood Marrow Transplant. 1999;5(3):123-32. doi: 10.1053/bbmt.1999.v5.pm10392958.
8
Inhibition of graft-versus-host disease by double-negative regulatory T cells.双阴性调节性T细胞对移植物抗宿主病的抑制作用。
J Immunol. 2003 Jul 1;171(1):134-41. doi: 10.4049/jimmunol.171.1.134.
9
Donor Allospecific CD44 Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease.供者同种异体 CD44 中央记忆 T 细胞介导移植物抗宿主病的能力降低。
Front Immunol. 2019 Apr 2;10:624. doi: 10.3389/fimmu.2019.00624. eCollection 2019.
10
Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.引发急性和慢性移植物抗宿主病的同种反应性CD4 T淋巴细胞存在于CD45RChigh亚群中,而不存在于CD45RClow亚群中。
Eur J Immunol. 2004 Feb;34(2):408-17. doi: 10.1002/eji.200324528.

引用本文的文献

1
Selective TCRαβ+ and CD45RA+ T-cell depletion of hematopoietic stem cell graft: An analysis on factors that affect depletion performance.造血干细胞移植物中TCRαβ+和CD45RA+ T细胞的选择性清除:影响清除效果的因素分析
Cell Transplant. 2025 Jan-Dec;34:9636897251336965. doi: 10.1177/09636897251336965. Epub 2025 May 8.
2
Cellular therapies for the prevention and treatment of acute graft-versus-host disease.用于预防和治疗急性移植物抗宿主病的细胞疗法。
Stem Cells. 2025 May 27;43(6). doi: 10.1093/stmcls/sxaf009.
3
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型:临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
4
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.经工程改造的人树突状细胞诱导的细胞毒性淋巴细胞介导强大的抗白血病活性。
Cancer Immunol Immunother. 2025 Feb 25;74(4):117. doi: 10.1007/s00262-025-03971-y.
5
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.记忆 T 细胞富集的半相合 NK 细胞回输移植具有良好的长期疗效:一项 II 期临床试验。
J Hematol Oncol. 2024 Jun 27;17(1):50. doi: 10.1186/s13045-024-01567-0.
6
Defining a TCF1-expressing progenitor allogeneic CD8 T cell subset in acute graft-versus-host disease.定义急性移植物抗宿主病中 TCF1 表达祖细胞同种异体 CD8 T 细胞亚群。
Nat Commun. 2023 Sep 22;14(1):5869. doi: 10.1038/s41467-023-41357-9.
7
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.解析移植物抗宿主病和移植物抗肿瘤中 T 细胞表型/功能的转录因子调控网络。
Front Immunol. 2023 Jun 27;14:1194984. doi: 10.3389/fimmu.2023.1194984. eCollection 2023.
8
Checkpoint Inhibitors in Acute Myeloid Leukemia.急性髓系白血病中的检查点抑制剂
Biomedicines. 2023 Jun 15;11(6):1724. doi: 10.3390/biomedicines11061724.
9
Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.免疫发病机制及调控策略在急性髓系白血病移植物抗宿主病预防中的作用。
Best Pract Res Clin Haematol. 2023 Jun;36(2):101475. doi: 10.1016/j.beha.2023.101475. Epub 2023 May 11.
10
TCF-1 Is Required for CD4 T Cell Persistence Functions during AlloImmunity.TCF-1 在同种异体免疫中 CD4 T 细胞持久功能中是必需的。
Int J Mol Sci. 2023 Feb 21;24(5):4326. doi: 10.3390/ijms24054326.

本文引用的文献

1
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.急性移植物抗宿主病早期事件的体内分析揭示了T细胞亚群的顺序性浸润。
Blood. 2005 Aug 1;106(3):1113-22. doi: 10.1182/blood-2005-02-0509. Epub 2005 Apr 26.
2
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.只有CD4+CD25+调节性T细胞的CD62L+亚群能预防致死性急性移植物抗宿主病。
Blood. 2005 Mar 1;105(5):2220-6. doi: 10.1182/blood-2004-05-2044. Epub 2004 Nov 16.
3
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.供体和宿主来源的抗原呈递细胞及共刺激分子在小鼠慢性移植物抗宿主病中的不同作用:需求因靶器官而异。
Blood. 2005 Mar 1;105(5):2227-34. doi: 10.1182/blood-2004-08-3032. Epub 2004 Nov 2.
4
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.高表达L-选择素(L-Selectin(hi))而非低表达L-选择素(L-selectin(lo))的CD4+25+调节性T细胞是移植物抗宿主病(GVHD)和骨髓移植排斥反应的有效抑制剂。
Blood. 2004 Dec 1;104(12):3804-12. doi: 10.1182/blood-2004-05-1850. Epub 2004 Aug 3.
5
Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules.巨细胞病毒特异性CD8 + T细胞与同种异体主要组织相容性复合体I类分子的交叉反应性。
Transplantation. 2004 Jun 27;77(12):1879-85. doi: 10.1097/01.tp.0000131158.81346.64.
6
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.造血干细胞剂量与干细胞移植后免疫重建的速度相关。
Blood. 2004 Jun 1;103(11):4344-52. doi: 10.1182/blood-2003-07-2534. Epub 2004 Feb 19.
7
Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.引发急性和慢性移植物抗宿主病的同种反应性CD4 T淋巴细胞存在于CD45RChigh亚群中,而不存在于CD45RClow亚群中。
Eur J Immunol. 2004 Feb;34(2):408-17. doi: 10.1002/eji.200324528.
8
Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity.树突状细胞激活的CD44高表达CD8 + T细胞在介导急性移植物抗宿主病方面存在缺陷,但保留了移植物抗白血病活性。
Blood. 2004 May 15;103(10):3970-8. doi: 10.1182/blood-2003-09-3135. Epub 2004 Feb 5.
9
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.异体CD62L记忆性T细胞的转移且无移植物抗宿主病。
Blood. 2004 Feb 15;103(4):1534-41. doi: 10.1182/blood-2003-08-2987. Epub 2003 Oct 9.
10
Memory CD4+ T cells do not induce graft-versus-host disease.记忆性CD4+ T细胞不会诱发移植物抗宿主病。
J Clin Invest. 2003 Jul;112(1):101-8. doi: 10.1172/JCI17601.